Thursday, September 24, 2026·Focal News

The Madison Focal

Madison's independent voice

Politics

Wisconsin residents may qualify for payments tied to alleged generic-drug price fixing

People who bought certain generic prescriptions in Wisconsin from May 2009 through December 2019 may be eligible for compensation under a newly approved settlement. The state Department of Justice says the case involves allegations that drug companies coordinated to limit competition and raise prices.

Wisconsin residents may qualify for payments tied to alleged generic-drug price fixing
MADISON, Wis. — Wisconsin residents who purchased certain generic prescription drugs over a 10-year period may be eligible for money from a preliminary settlement involving alleged price fixing by drug manufacturers. The Wisconsin Department of Justice announced the settlement Wednesday, saying consumers who bought qualifying medications between May 2009 and December 2019 can check whether they are eligible to file a claim. Wisconsin and 47 other states allege that dozens of generic-drug companies worked together to discourage competition and increase prices. The first lawsuit in the broader litigation was filed about a decade ago, and courts granted preliminary approval this month for settlement funds to begin being distributed. “​​We remain committed to working with other states and continuing to seek accountability in this matter,” Wisconsin Attorney General Josh Kaul said in a statement. “We take very seriously allegations that prices were manipulated. It’s particularly important at a time when so many Wisconsinites are concerned about affordability issues.” The settlement is not the end of the broader litigation. Several other cases against drug manufacturers remain pending, according to the Wisconsin DOJ. Consumers can begin by reviewing the list of generic drugs covered by the settlement at AGGenericDrugs.com. They must also confirm that their purchases occurred within the eligible period. Questions and claims can be directed to the settlement administrator at 1-866-290-0182 or info@AGGenericDrugs.com. Information and claim materials are also available at agg​enericdrugs.com/English/landing/portalid/0?portalid=0. The settlement administrator’s website should be used to verify eligibility and obtain the applicable filing instructions. Consumers should be cautious of unsolicited requests for payment or personal financial information from people claiming to represent the settlement.

More from The Madison Focal